• LAST PRICE
    3.4700
  • TODAY'S CHANGE (%)
    Trending Down-0.1900 (-5.1913%)
  • Bid / Lots
    3.4700/ 2
  • Ask / Lots
    3.6000/ 1
  • Open / Previous Close
    3.6700 / 3.6600
  • Day Range
    Low 3.4600
    High 3.6700
  • 52 Week Range
    Low 3.2700
    High 14.2200
  • Volume
    364,636
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 3.66
TimeVolumeVSTM
09:32 ET92333.64
09:34 ET3963.64
09:36 ET9283.63
09:38 ET11003.62
09:39 ET2883.64
09:41 ET29153.59
09:43 ET1653.5912
09:45 ET38933.6
09:48 ET23853.57
09:50 ET20863.5612
09:52 ET37313.555
09:54 ET56143.55
09:56 ET7503.56
09:57 ET2143.57
09:59 ET11003.58
10:01 ET8503.57
10:03 ET1003.555
10:06 ET89193.565
10:08 ET172993.57
10:10 ET47563.58
10:12 ET16643.56
10:15 ET2003.57
10:21 ET12003.58
10:26 ET1003.58
10:28 ET29463.5977
10:30 ET2003.6
10:32 ET4503.61
10:33 ET6973.6
10:37 ET22393.6
10:39 ET8003.61
10:44 ET16003.62
10:46 ET38563.6401
10:48 ET11433.63
10:50 ET1003.6395
10:51 ET3003.625
10:53 ET1003.63
10:55 ET15503.62
11:00 ET3023.63
11:02 ET1003.64
11:08 ET26003.6499
11:11 ET42323.615
11:13 ET24793.62
11:20 ET8003.615
11:24 ET11703.61
11:26 ET2003.6212
11:27 ET3503.6228
11:31 ET5773.625
11:33 ET27413.6269
11:36 ET41323.61
11:40 ET7973.6
11:42 ET14363.59
11:45 ET6623.595
11:47 ET9663.6
11:49 ET16383.605
11:51 ET1573.61
11:54 ET1003.6
11:58 ET19133.59
12:00 ET19553.595
12:02 ET1003.59
12:05 ET6003.58
12:07 ET12653.585
12:14 ET12373.6
12:18 ET7253.6001
12:23 ET10383.605
12:30 ET31983.5786
12:36 ET4543.58
12:38 ET1003.57
12:39 ET1003.58
12:41 ET1003.57
12:43 ET5003.575
12:45 ET4013.57
12:48 ET7003.57
12:50 ET1003.56
12:52 ET6663.565
12:54 ET210003.54
12:56 ET13063.54
12:57 ET31473.5336
12:59 ET6003.535
01:01 ET127003.545
01:14 ET22003.5633
01:21 ET14433.55
01:24 ET16753.555
01:26 ET19003.56
01:30 ET10513.56
01:32 ET34773.56
01:35 ET2503.5599
01:37 ET1003.55
01:42 ET4003.55
01:44 ET47743.555
01:46 ET1003.55
01:50 ET1003.55
01:51 ET11003.55
01:53 ET2003.55
01:55 ET4003.55
01:57 ET20003.55
02:00 ET30883.545
02:02 ET24003.55
02:04 ET7723.555
02:06 ET25483.555
02:08 ET2003.555
02:09 ET45723.53
02:11 ET1003.525
02:13 ET23623.52
02:15 ET20003.5206
02:18 ET13903.5112
02:20 ET19533.52
02:22 ET1003.52
02:26 ET7003.52
02:27 ET24313.52
02:29 ET5003.53
02:40 ET5683.52
02:42 ET30003.51
02:44 ET1003.505
02:45 ET1003.5099
02:47 ET147753.495
02:49 ET2003.495
02:51 ET17433.5
02:58 ET5003.5099
03:00 ET13523.51
03:02 ET1003.52
03:05 ET1003.51
03:07 ET13683.51
03:09 ET38253.49
03:12 ET1003.49
03:14 ET4003.49
03:16 ET4003.49
03:18 ET39323.485
03:21 ET1003.48
03:23 ET2893.48
03:25 ET9453.485
03:27 ET60733.495
03:30 ET8003.49
03:32 ET3003.49
03:34 ET1003.49
03:36 ET1003.4988
03:38 ET2003.49
03:39 ET54753.49
03:41 ET25753.485
03:43 ET71303.49
03:45 ET70003.5
03:48 ET66163.495
03:50 ET12953.49
03:52 ET13193.49
03:54 ET6003.49
03:56 ET66213.475
03:57 ET61773.46
03:59 ET71233.47
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVSTM
Verastem Inc
87.9M
-0.8x
---
United StatesCNTB
Connect Biopharma Holdings Ltd
88.2M
-1.5x
---
United StatesALVR
Allovir Inc
87.5M
-0.5x
---
United StatesCGTX
Cognition Therapeutics Inc
86.9M
-2.4x
---
United StatesSLS
Sellas Life Sciences Group Inc
86.6M
-1.3x
---
United StatesMAIA
Maia Biotechnology Inc
86.3M
-2.5x
---
As of 2024-06-15

Company Information

Verastem, Inc. is a late-stage development biopharmaceutical company. The Company's pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibition and focal adhesion kinase (FAK) inhibition. The Company’s advanced product candidates, avutometinib and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors, including low-grade serous ovarian cancer (LGSOC), non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer (CRC), and melanoma. Avutometinib is an orally available small molecule RAF/MEK clamp that inhibits the ras sarcoma (RAS)/RAF/MEK, ERK mitogen activated pathway kinase (MAPK) pathway. Defactinib is an oral small molecule inhibitor of FAK and proline-rich tyrosine kinase (PYK2).

Contact Information

Headquarters
117 Kendrick Street, Suite 500CAMBRIDGE, MA, United States 02494
Phone
781-292-4200
Fax
302-655-5049

Executives

President, Chief Executive Officer, Director
Daniel Paterson
Chief Financial Officer
Daniel Calkins
Independent Director
Paul Bunn
Independent Director
Anil Kapur
Independent Director
Michelle Robertson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$87.9M
Revenue (TTM)
$0.00
Shares Outstanding
25.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.21
EPS
$-4.40
Book Value
$3.11
P/E Ratio
-0.8x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.